About us

The Clinical Trials Team:

Key team members with 20+ years experience of patient phototoxicity and in conducting phase1-phototoxicity trials and a proven track record with the pharmaceutical industry.

Professor James Ferguson MD, FRCP, is a renowned academic and clinician with significant publications in the area of drug induced phototoxicity as well as the fields of phototherapy, photochemotherapy and the photodermatoses , the clinical and laboratory study of drug induced phototoxicity, particularly the fluoroquinolones; the study of the natural history and treatment of the photosensitivity disorders.

The experienced team at Spectratox offers a seamless service where the quality of pre clinical laboratory data analysis is combined with the ability to perform volunteer and additional post study scientific testing or research as necessary. Should a positive result be produced, advice on product labeling and clinical management is available.

Spectratox is a limited company with the Photobiology Trust as the sole shareholder.

Registered office: Kinburn Castle, St Andrews, Scotland, KY16 9DR
Registered number is SC328032.